Medical device peers Alcon, Cooper Cos. and Johnson & Johnson own 25% to 40% of the market for contact lenses vs. 10% for Bausch + Lomb. In pharmaceuticals, AbbVie would encounter antitrust ...

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and ...

Vision Care Returns to Growth: Within Vision Care, Alcon is registering solid growth, banking on strong sales of its contact lenses and ocular health products. In contact lenses, Alcon ...

when he signed an appointment of eight members of a 12-person panel that considered approval of a lens implant by Alcon, an eye care drug and device maker and a client of Ms. Shuren’s.

Within Vision Care, Alcon is registering solid growth, banking on strong sales of its contact lenses and ocular health ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Johnson & Johnson (NYSE: JNJ) expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

Advancements and Projections in the Ophthalmic Devices Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...

Edetate disodium (EDTA) is a chelating agent used in a variety of nonophthalmic products, including hair ... Polyquad was formulated in the mid 1980s by Alcon as a preservative for contact lens ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...